Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis
Authors:
- Cg IslesCICg Isles
- H LooseHLH Loose
Open Access
- 1 May 1998
- journal article
- clinical trial
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 12 (5) , 329-335
Abstract
Background: Data from randomised studies are lacking on the value of interventional procedures in the management of atheromatous renal artery stenosis. This randomised prospective trial compared the effects on blood pressure (BP) and renal function of percutaneous transluminal angioplasty vs medical therapy in hypertensive patients with both unilateral and bilateral disease. Methods: A total of 135 eligible patients were identified, of whom 55 (44%) were randomised. Eligible patients had sustained hypertension, with a minimum diastolic BP of 95 mm Hg on at least two anti-hypertensive drugs. Renal artery stenosis was defined by renal angiography as at least 50% stenosis in the affected vessel. All patients were observed during an initial 4-week run-in period on a fixed drug regimen and subsequent changes measured from this 4-week baseline. Results: Blood pressure fell during the run-in period in all groups. In patients with bilateral renal artery stenosis randomised to angioplasty, a statistically significant (P < 0.05) fall in bp was observed at latest follow-up (range 3–54 months). the mean fall in bp at latest follow- up in the angioplasty group, corrected for the medical group response, was 26/10 mm hg. in patients with unilateral renal artery stenosis, no statistically significant or clinically important differences in outcome were observed between the two groups. no significant differences or trends in serum creatinine were observed between or within any group during follow-up. major outcome events (death, myocardial infarction, heart failure, stroke, dialysis) were similar in the angioplasty and medical groups during follow-up. in the 40/135 patients undergoing angioplasty, serious or potentially serious complications attributable to the procedure were observed in 11 patients, bleeding at the arterial site (8 patients) being the most frequent. Conclusions: In hypertensive patients with atheromatous renal artery stenosis, percutaneous renal angioplasty results in a modest improvement in systolic BP compared with medical therapy alone. This benefit was confined to patients with bilateral disease. No patient was ‘cured’, renal function did not improve, and intervention was accompanied by a significant complication rate.Keywords
This publication has 8 references indexed in Scilit:
- Management of renovascular disease: a review of renal artery stenting in ten studiesQJM: An International Journal of Medicine, 1999
- Effect of renal-artery stenting on progression of renovascular renal failureThe Lancet, 1997
- Treatment of Ostial Renal-Artery Stenoses with Vascular Endoprostheses after Unsuccessful Balloon AngioplastyNew England Journal of Medicine, 1997
- Transluminal vascular stent for ostial atherosclerotic renal artery stenosisThe Lancet, 1995
- Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study.Radiology, 1991
- Survival Associated with Renovascular Disease in Glasgow and Newcastle: A Collaborative StudyScottish Medical Journal, 1990
- Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series.BMJ, 1990
- Percutaneous Transluminal Renal Angioplasty in Renovascular Hypertension Due to Atheroma or Fibromuscular DysplasiaNew England Journal of Medicine, 1983